toripalimab,regorafenib
junshi biosciences,coherus,bayer
['toripalimab', 'rectal', 'regorafenib', 'colorectal']
regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase ib/ii clinical trial and gut microbiome analysis - read more from &amp; researchers from sun yat-sen university cancer center #asco23 
Cell Press partners with scientists across all disciplines to publish and share work that will inspire future directions in research. #ScienceThatInspires